Preferred Label : belantamab mafodotin;
MeSH hyponym : GSK-2857916; GSK 2857916;
UNII : DB1041CXDG;
Origin ID : C000631691;
UMLS CUI : C5227411;
ATC code(s)
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-acces-derogatoire/blenrep
2024
false
false
false
France
French
infusions, intravenous
drug information
antibodies, monoclonal, humanized
belantamab mafodotin
Antineoplastic Agents, Immunological
---
https://ansm.sante.fr/informations-de-securite/blenrep-belantamab-mafodotin-et-myelome-multiple-lema-recommande-de-ne-pas-renouveler-son-amm-conditionnelle-en-raison-dun-manque-de-preuve-defficacite
2023
false
false
false
France
French
drug information
treatment outcome
belantamab mafodotin
---
https://www.has-sante.fr/jcms/p_3471810/fr/blenrep-belantamab-mafodotin-myelome-multiple
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
belantamab mafodotin
infusions, intravenous
adult
Refractory Multiple Myeloma
evaluation of the transparency committee
belantamab mafodotin
multiple myeloma
---
https://www.ema.europa.eu/en/medicines/human/EPAR/blenrep
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Belantamab Mafodotin
Belantamab Mafodotin
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
antineoplastic agents
antineoplastic agents
multiple myeloma
adult
orphan drug production
infusions, intravenous
continuity of patient care
drug monitoring
belantamab mafodotin
product surveillance, postmarketing
aged
pregnancy
breast feeding
fertility
drug evaluation, preclinical
belantamab mafodotin
belantamab mafodotin
b-cell maturation antigen
---
https://www.has-sante.fr/jcms/p_3224946/fr/blenrep
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
infusions, intravenous
Belantamab Mafodotin
antibodies, monoclonal, humanized
adult
antineoplastic agents
Belantamab Mafodotin
antibodies, monoclonal, humanized
multiple myeloma
belantamab mafodotin
belantamab mafodotin
belantamab mafodotin
---